Kim Kelderman

Insider profile

Currently holds a position at Bio-Techne Corporation

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President - Diagnostics and Genomics Bio-Techne Corporation April 30, 2018 -
Kim Kelderman's trades of Bio-Techne Corporation's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
118.12
Quantity 53,190 -44.1%
Value US$1,984,795
Transaction date
Sale
Price
336.86
Quantity 56,153 -47.7%
Value US$2,342,535
Transaction date
Proposed sale
Price
169.89
Quantity 27,875
Value US$2,043,312
Transaction date
Sale
Price
503.76
Quantity 100 -20.0%
Value US$50,376
Transaction date
Sale
Price
388.45
Quantity 823 -49.3%
Value US$319,694
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-29 2025-01-27
S Sale
53,190 -44.1%
118.12
US$1,984,795 		53,190 -44.1% 118.12 US$1,984,795
2025-01-29 2025-01-27
S Sale
56,153 -47.7%
336.86
US$2,342,535 		56,153 -47.7% 336.86 US$2,342,535
2025-01-27 2025-01-27
PrS Proposed sale
27,875
169.89
US$2,043,312 		27,875 169.89 US$2,043,312
2021-11-23 2021-11-19
S Sale
400 -100.0%
505.78
US$202,313 		400 -100.0% 505.78 US$202,313
2021-11-23 2021-11-19
S Sale
100 -20.0%
503.76
US$50,376 		100 -20.0% 503.76 US$50,376
2021-02-09 2021-02-05
S Sale
823 -49.3%
388.45
US$319,694 		823 -49.3% 388.45 US$319,694